Companies Clinch Deals for Global Biosimilar Commercialization - The Center for Biosimilars

Prestige Biopharma and Intas Pharmaceuticals join forces to partner on a bevacizumab biosimilar for multiple countries, and Hikma Pharmaceuticals makes a deal with Celltrion Healthcare for the commercialization of an adalimumab biosimilar.

In a single week, Prestige Biopharma and Intas Pharmaceuticals plus Hikma Pharmaceuticals and Celltrion Healthcare entered into commercialization agreements for a bevacizumab biosimilar and an adalim… [+3337 chars]

full article...